182 related articles for article (PubMed ID: 37127041)
21. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
Batawil N; Alkordy T
Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial.
Livhits MJ; Zhu CY; Kuo EJ; Nguyen DT; Kim J; Tseng CH; Leung AM; Rao J; Levin M; Douek ML; Beckett KR; Cheung DS; Gofnung YA; Smooke-Praw S; Yeh MW
JAMA Oncol; 2021 Jan; 7(1):70-77. PubMed ID: 33300952
[TBL] [Abstract][Full Text] [Related]
23. The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology.
Duick DS; Klopper JP; Diggans JC; Friedman L; Kennedy GC; Lanman RB; McIver B
Thyroid; 2012 Oct; 22(10):996-1001. PubMed ID: 22873825
[TBL] [Abstract][Full Text] [Related]
24. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of sonographic features in indeterminate pediatric thyroid nodules.
Richman DM; Cherella CE; Smith JR; Modi BP; Zendejas B; Frates MC; Wassner AJ
Eur J Endocrinol; 2021 May; 184(5):657-665. PubMed ID: 33635830
[TBL] [Abstract][Full Text] [Related]
26. Real-world Comparison of Afirma GEC and GSC for the Assessment of Cytologically Indeterminate Thyroid Nodules.
San Martin VT; Lawrence L; Bena J; Madhun NZ; Berber E; Elsheikh TM; Nasr CE
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31665322
[TBL] [Abstract][Full Text] [Related]
27. Completion thyroidectomy: predicting bilateral disease.
Ibrahim B; Forest VI; Hier M; Mlynarek AM; Caglar D; Payne RJ
J Otolaryngol Head Neck Surg; 2015 Jun; 44(1):23. PubMed ID: 26077153
[TBL] [Abstract][Full Text] [Related]
28. Large, Slowly Growing, Benign Thyroid Nodules Frequently Coexist With Synchronous Thyroid Cancers.
Paparodis RD; Karvounis E; Bantouna D; Chourpiliadis C; Hourpiliadi H; Livadas S; Imam S; Jaume JC
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3474-e3478. PubMed ID: 35436327
[TBL] [Abstract][Full Text] [Related]
29. Is conservative management of the indeterminate thyroid nodule [Thy3f or Bethesda category IV] safe?
Gaunt A; Moore AR; Huvenne C; Dhami A; Eades M; Balasubramanian SP
Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5905-5911. PubMed ID: 35881191
[TBL] [Abstract][Full Text] [Related]
30. Thyroglobulin antibodies as a potential predictive marker of papillary thyroid carcinoma in patients with indeterminate cytology.
Karatzas T; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Boutzios G
Am J Surg; 2016 Nov; 212(5):946-952. PubMed ID: 27324384
[TBL] [Abstract][Full Text] [Related]
31. The role of thyroid sonographic malignancy risk features when the fine needle aspiration biopsy result is indeterminate.
Kotecka-Blicharz A; Krzempek M; Cortez AJ; Oczko-Wojciechowska M; Czarniecka A; Nożyńska E; Chmielik E; Jarząb B; Krajewska J
Endokrynol Pol; 2022; 73(2):316-324. PubMed ID: 35593681
[TBL] [Abstract][Full Text] [Related]
32. Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology.
Rago T; Scutari M; Santini F; Loiacono V; Piaggi P; Di Coscio G; Basolo F; Berti P; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2010 Dec; 95(12):5274-80. PubMed ID: 20810572
[TBL] [Abstract][Full Text] [Related]
33. How to approach thyroid nodules with indeterminate cytology.
Yoon JH; Kwak JY; Kim EK; Moon HJ; Kim MJ; Kim JY; Koo HR; Kim MH
Ann Surg Oncol; 2010 Aug; 17(8):2147-55. PubMed ID: 20217250
[TBL] [Abstract][Full Text] [Related]
34. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
35. Clinical Use of Raman Spectroscopy Improves Diagnostic Accuracy for Indeterminate Thyroid Nodules.
Palermo A; Sodo A; Naciu AM; Di Gioacchino M; Paolucci A; di Masi A; Maggi D; Crucitti P; Longo F; Perrella E; Taffon C; Verri M; Ricci MA; Crescenzi A
J Clin Endocrinol Metab; 2022 Nov; 107(12):3309-3319. PubMed ID: 36103268
[TBL] [Abstract][Full Text] [Related]
36. Active surveillance in small cytological indeterminate thyroid nodules: a call to common sense?
Smulever A; Pitoia F
Endocrine; 2021 May; 72(2):505-512. PubMed ID: 33411327
[TBL] [Abstract][Full Text] [Related]
37. Management of Sonographically Suspicious Thyroid Nodules 1 cm or Smaller and Candidacy for Active Surveillance: Experience of a Tertiary Center in China.
Hu YL; Cao XY; Zhou YR; Ye XH; Wang JX; Li X; Rong R; Shen MP; Wu XH
Endocr Pract; 2021 Sep; 27(9):903-911. PubMed ID: 33607263
[TBL] [Abstract][Full Text] [Related]
38. Adolescents with thyroid nodules: retrospective analysis of factors predicting malignancy.
Suh J; Choi HS; Kwon A; Chae HW; Kim HS
Eur J Pediatr; 2020 Feb; 179(2):317-325. PubMed ID: 31741093
[TBL] [Abstract][Full Text] [Related]
39. Pediatric thyroid nodules: insights in management.
Lugo-Vicente H; Ortíz VN
Bol Asoc Med P R; 1998; 90(4-6):74-8. PubMed ID: 9866271
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of malignancy within cytologically indeterminate thyroid nodules.
Miller B; Burkey S; Lindberg G; Snyder WH; Nwariaku FE
Am J Surg; 2004 Nov; 188(5):459-62. PubMed ID: 15546550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
